12
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

      Submit here before July 31, 2024

      About Blood Purification: 3.0 Impact Factor I 5.6 CiteScore I 0.83 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Pregnancy Outcomes in French Hemodialysis Patients

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Pregnancy in hemodialysis (HD) women is a rare event and often associated with maternal and fetal complications. Scarcity of available data from large cohorts impedes fair medical counseling. Methods: This is a descriptive, retrospective, multi-centric study. Pregnant women on HD during the period from 1985 to 2015 in France were included. The primary outcome was a living infant discharged from hospital, while secondary outcomes included gestational age and birth weight. Results: We identified 100 pregnancies in 84 women on HD, from 41 centers. Chronic HD was initiated during pregnancy for 17.7% (14/79) of patients explaining a 19.8% prevalence of catheter (19/96) and a preserved residual diuresis for 50% of pregnancy (43/86). Seventy-six (89.4%) women performed daily dialysis during the third trimester (6 times per week). Our primary outcome was met for 78% of newborns with a mean gestational age of 33.2 ± 3.9 weeks and a mean birth weight of 1,719 ± 730 g. Conclusions: Our study is one of the largest series of ­pregnancies in HD patients. Despite recent progresses, these pregnancies remain at high risk, reinforcing the need for an early nephrologist-obstetrician skilled team co-management.

          Related collections

          Author and article information

          Journal
          AJN
          Am J Nephrol
          10.1159/issn.0250-8095
          American Journal of Nephrology
          S. Karger AG
          0250-8095
          1421-9670
          2018
          May 2018
          27 March 2018
          : 47
          : 4
          : 219-227
          Affiliations
          [_a] aService de Néphrologie, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
          [_b] bService de Néphrologie, Hôpital d’Amiens, CHU Amiens- Picardie, Amiens, France
          [_c] cUniversité de Lyon, Université Lyon 1, Lyon, France
          [_d] dUnité de recherche Clinique du pole IMER of the Hospices Civils de Lyon, Lyon, France
          [_e] eService de Gynécologie Obstétrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France
          Author notes
          *Gabrielle Laetitia Normand, Service de Néphrologie Clinique et Hypertension Artérielle, Pavillon P, 5, Place d’Arsonval, Hôpital Edouard HERRIOT, FR–69003 Lyon (France), E-Mail laetitia.normand@chu-lyon.fr
          Article
          488286 Am J Nephrol 2018;47:219–227
          10.1159/000488286
          29587251
          5233783a-8458-42f8-82bf-3828c9941390
          © 2018 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 13 January 2018
          : 03 March 2018
          Page count
          Figures: 1, Tables: 4, Pages: 9
          Categories
          Original Report: Patient-Oriented, Translational Research

          Cardiovascular Medicine,Nephrology
          Chronic renal insufficiency,Pregnancy,Dialysis
          Cardiovascular Medicine, Nephrology
          Chronic renal insufficiency, Pregnancy, Dialysis

          Comments

          Comment on this article